现在位置 >首页 > 时讯速递
[BMJ发表论文]:来自论文工厂的撤稿已关闭评论
Research Retracted papers originating from paper mills: cross sectional study Cristina Candal-Pedreira, Joseph S Ross, Alberto Ruano-Ravina, et al BMJ 2022; 379 doi: https://doi.org/10.1136/bmj-2022-071517 (Published 28 November 2022)Cite this as: BMJ 2022;379:e071517 Abstract Objectives To describe retracted papers originating from paper mills, including their characteristics, visibility, and impact over time, and the journals in which they were publi...
阅读全文
[Lancet Respir Med发表论文]:利妥昔单抗与静脉环磷酰胺治疗结缔组织病相关肺间质病已关闭评论
ARTICLES|ONLINE FIRST Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial Toby M Maher, Veronica A Tudor, Peter Saunders, et al. Lancet Respir Med Published:November 11, 2022 DOI:https://doi.org/10.1016/S2213-2600(22)00359-9 Summary Background Rituximab is often used as rescue therapy in in...
阅读全文
[Clin Infect Dis发表论文]:法匹拉韦治疗无症状或非复杂性新冠肺炎门诊患者已关闭评论
Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial  Marisa Holubar,  Aruna Subramanian,  Natasha Purington,  et al Clinical Infectious Diseases, Volume 75, Issue 11, 1 December 2022, Pages 1883–1892, https://doi.org/10.1093/cid/ciac312 Abstract Background Favipiravir, an oral, RNA-dependent RNA polymerase inhibitor, has in vitroactivity...
阅读全文
[BMJ发表论文]:有关干预措施的系统回顾与meta分析报告与分享数据方式的改变已关闭评论
Research Changing patterns in reporting and sharing of review data in systematic reviews with meta-analysis of the effects of interventions: cross sectional meta-research study Phi-Yen Nguyen, Raju Kanukula, Joanne E McKenzie, et al BMJ 2022; 379 doi: https://doi.org/10.1136/bmj-2022-072428 (Published 22 November 2022)Cite this as: BMJ 2022;379:e072428 Abstract Objectives To examine changes in completeness of reporting and frequency of sharing data, an...
阅读全文
[NEJM发表论文]:脓毒症诱导低血压的早期限制性或自由性液体治疗已关闭评论
ORIGINAL ARTICLE Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension The National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network N Engl J Med January 21, 2023DOI: 10.1056/NEJMoa2212663 Abstract BACKGROUND Intravenous fluids and vasopressor agents are commonly used in early resuscitation of patients with sepsis, but comparative data for prioritizing their delivery are l...
阅读全文
[BMJ发表论文]:社区无症状新冠病毒快速抗原检测对新冠肺炎相关住院的影响已关闭评论
Research Impact of community asymptomatic rapid antigen testing on covid-19 related hospital admissions: synthetic control study Xingna Zhang, Ben Barr, Mark Green, et al BMJ 2022; 379 doi: https://doi.org/10.1136/bmj-2022-071374 (Published 23 November 2022)Cite this as: BMJ 2022;379:e071374 Abstract Objective To analyse the impact of voluntary rapid testing for SARS-CoV-2 antigen in Liverpool city on covid-19 related hospital admissions. Design&nbs...
阅读全文
[Lancet Respir Med发表论文]:抗C5a抗体治疗接受有创机械通气的重症新冠肺炎住院患者已关闭评论
ARTICLES| VOLUME 10, ISSUE 12, P1137-1146, DECEMBER 01, 2022 Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Alexander P J Vlaar, Martin Witzenrath, Pieter van Paassen, et al. Lancet Respir Med 2022; 10: 1137-1146 Published:September 07, 2022 DOI: https://doi.org/10.1016/S2213-2600(22)00297-1 ...
阅读全文
[JAMA研究来信]:俄勒冈波特兰和华盛顿西雅图2021年热浪与急诊科就诊的相关性已关闭评论
Research Letter  Climate Change and Health December 20, 2022 Association Between the 2021 Heat Wave in Portland, Oregon, and Seattle, Washington, and Emergency Department Visits Amruta Nori-Sarma, Chad Milando, Kate R. Weinberger, et al JAMA. 2022;328(23):2360-2362. doi:10.1001/jama.2022.20665 Heat waves are becoming more frequent and severe, with pronounced effects on human health.1 In late June 2021, temperatures in the US Pacific N...
阅读全文
[JAMA发表论文]:REMAP-CAP随机临床试验中新冠肺炎危重病患者的长期(180天)预后已关闭评论
Original Investigation  Caring for the Critically Ill Patient December 16, 2022 Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial Writing Committee for the REMAP-CAP Investigators JAMA. Published online December 16, 2022. doi:10.1001/jama.2022.23257 Key Points Question  What is the effect of treatment for critically ill patients with COVID-19 on longer-term mortali...
阅读全文
[BMJ发表论文]:有症状的远端DVT患者接受利伐沙班治疗6周或3个月已关闭评论
Research Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial Walter Ageno, Lorenza Bertù, Eugenio Bucherini, et al BMJ 2022; 379 doi: https://doi.org/10.1136/bmj-2022-072623 (Published 23 November 2022)Cite this as: BMJ 2022;379:e072623 Abstract Objective To compare two different treatment durations of rivaroxaban in patients with symptomatic isolated di...
阅读全文
×
腾讯微博